Polymorphisms of angiotensin converting enzyme and plasminogen activator inhibitor-1 genes in diabetes and macroangiopathy

Kidney International

Volumn 54, Issue 5, 1998, Pages 1659-1669

  Kimura, Hideki ^a   Gejyo, Fumitake ^b   Suzuki, Yoshiki ^b   Suzuki, Satoru ^b   Miyazaki, Ryoichi ^b   Arakawa, Masaaki ^b  

^a UNIVERSITY OF FUKUI   (Japan)

^b NONE

Author keywords

ACE; Diabetic nephropathy; Macroangiopathy; PAI 1; Polymorphism; Synergistic effect

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; AGED; ARTICLE; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY; FEMALE; GENE DELETION; GENE INSERTION; GENETIC POLYMORPHISM; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0031727745     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00139.x     Document Type: Article

References (43)

1. MOGENSEN CE: Microalbuminuria predicts clinical proteinuria and early mortality on maturity-onset diabetes. N Engl J Med 310:356-360, 1984
2. SUZUKI Y, ARAKAWA M, GEJYO F, COLLABORATE STUDY GROUP: The treatment of the uremic diabetic. Are we doing enough? A view from Japan. Nephrol Dial Transplant 10(Suppl 7):47-55, 1995
3. HANSSEN KF, DAHL-JORGENSEN K, LAURITZEN T: Diabetic control and microvascular conditions. Diabetologia 29:677-684, 1986
4. HASSLACHER C, RITZ E, TSCHOPE W: Hypertension and diabetes mellitus. Kidney Int 34(Suppl):S133-S137, 1988
5. BALLARD DJ, HUMPHREY LL, MELTON LJ III: Epidemiology of persistent proteinuria in type II diabetes mellitus. Population-based study in Rochester, Minnesota. Diabetes 37:405-412, 1988
6. PETTITT DJ, SAAD MF, BENNETT PH: Familial predisposition to renal disease in two generations of Pima Indians with Type 2 non-insulin-dependent diabetes mellitus. Diabetologia 33:438-443, 1990
7. YUSUF SC, PEPINE CJ, GARCES C, POULEUR H, SALEM D, KOSTIS J, BENED C, BOURASSA M, PITT B: Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection tractions. Lancet 340:1173-1178, 1992
8. PFEFFER MA, BRAUNWALD E, MOYE LA, BASTA L, BROWN EJ JR, CUDDY TE, DAVIS BR, GELTMAN EM, GOLDMAN S, FLAKER GC: Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial. N Engl J Med 327:669-677, 1992
9. LEWIS EJ, HUNSICKERS LG, BIN RP, ROHDE RD: The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. N Engl J Med 329:1456-1462, 1993
10. MARRE M, BERNADET P, GALLOIS Y, SAVAGNER F, GUYENE T-T, HALLAB M, CAMBIEN F, PASSA P, ALHENC-GELAS F: Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes 43:384-388, 1994
11. YOSHIDA H, KURIYAMA S, ATSUMI Y, TOMONARI H, MITARAI T, HAMAGUCHI A, KUBO H, KAWAGUCHI Y, KON V, MATSUOKA K, ICHIKAWA I, SAKAI O: Angiotensin I converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus. Kidney Int 50:657-664, 1996
12. DORIA A, WARRAM JH, KROLEWSKI AS: Genetic predisposition to diabetic nephropathy. Evidence for a role of the angiotensin 1-converting enzyme gene. Diabetes 43:690-695, 1994
13. CAMBIEN F, POIRIER O, LECERF L, EVANS A, CAMBOU JP, ARVEILER D, LUC G, BARD JM, BARA L, RICARD S, TIRET L, AMOUYEL P, ALHENC-GELAS F, SOUBRIER F: Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359:641-644, 1992
14. RAYNOLDS MV, BRISTOW MR, BUSH EW, ABRAHAM WT, LOWER BD, ZISMAN LS, TAFT CS, PERRYMAN MB: Angiotensin-converting enzyme DD genotype in patients with ischemic or idiopathic dilated cardiomyopathy. Lancet 342:1073-1075, 1993
15. RIGAT B, HUBERT C, ALHENC-GELAS F, CAMBIEN F, CORVOL P, SOUBRIER F: An insertion/deletion polymorphism in the angiotensin-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343-1346, 1990
16. COSTEROUSSE O, ALLEGRINI J, LOPEZ M, ALHENC-GELAS F: Angiotensin-converting enzyme in human circulating mononuclear cells: Genetic polymorphism of expression in T-lymphocytes. Biochem J 290:33-40, 1993
17. RAY PE, BRUGGEMAN LA, HORIKOSHI S, AGUILLER G, KOLTMAN P: Angiotensin II stimulates human fetal mesangial cell proliferation and fibronectin biosynthesis by binding to AT1 receptors. Kidney Int 45:177-184, 1994
18. PAOUET JL, BAUDOUIN-LEGROS M, BRUNELLE G, MEYER P: Angiotensin II-induced proliferation of aortic myocytes in spontaneously hypertensive rats. J Hypertens 8:565-572, 1990
19. FEENER EP, NORTHRUP JM, AIELLO LP, KING LP: Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells. J Clin Invest 95:1353-1362, 1995
20. KAGAMI S, OKADA K, KURODA Y, BORDER WA, NOBEL NA: Effect of angiotensin II on the expression of plasminogen activator inhibitor (PAI)-1 in rat mesangial cells. (abstract) J Am Soc Nephrol 5:810, 1994
21. VASSALLI J-D, SAPPINO A-P, BELIN D: The plasminogen activator, plasmin system. J Clin Invest 88:1067-1072, 1991
22. HAMDAN AD, QUIST WC, GAGNE JB, FEENER EP: Angiotensin converting enzyme inhibition suppresses plasminogen activator inhibitor-1 expression in the neointima of balloon-injured rat aorta. Cirulation 93:1073-1078, 1996
23. OIKAWA T, FREEMAN M, LO W, VAUGHAN DE, FOGO A: Modulation of plasminogen activator inhibitor-1 in vivo: A new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition. Kidney Int 51:164-172, 1997
24. DAWSON SJ, WIMAN B, HAMSTEN A, GREEN F, HUMPHERIS SE, HENNEY AM: The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells. J Biol Chem 268:10739-10745, 1993
25. ERIKSSON P, KALLIN B, VAN'T HOOFT FM, BAVENHOLM P, HAMSTEN A: Allele-specific increase in basal transcription of the plasminogen activator inhibitor 1 gene is associated with myocardial infarction. Proc Natl Acad Sci USA 92:1851-1855, 1995
26. BARICOS WH, CORTZ SL, EL-DAHR SS, SCHNAPER W: ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade. Kidney Int 47:1039-1047, 1995
27. ROSE GA, BLACKBURN H, GILLUM RF, PRINEAS RJ: Cardiovascular Surgery Methods (2nd ed), Geneva, World Health Organization, 1982
28. RIGAT B, HUBERT C, CORVOL P, SOUBRIER F: PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). (abstract) Nucleic Acids Res 20:1443, 1992
29. LINDPAINTSER K, PFEFFER MA, KREUTZ R, STAMPFER MJ, GRODSTEIN F, LAMOTTH F, BURING J, HENNEKENS H: A prospective evaluation of an angiotensin-converting enzyme gene polymorphism and the risk of ischemic heart disease. N Engl Med 322:706-711, 1995
30. SAS INSTTUTT INC: SAS Technical Report P-217, Sas/stat Software The PHREG, Procedure, Version 6.07. Cary, SAS Institute Inc, 1991
31. YE S, GREE FR, SCARABIN PY, NICAUD V, BARA L, DAWSON SJ, HUMPHRIES SE, EVANS A, LUC G, CAMBOU JP, ARVEILER D, HENNY AM, CAMBIEN F: The 4G/5G genetic polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene is associated with difference in plasma PAI-1 activity hut not with risk of myocardial infarction in the ECTIM study. Thromb Haemost 74:837-841, 1995
32. MANSFIELD MW, STICKLAND MH, GRANT PJ: Environmental and genetic factors in relation to elevated circulating levels of plasminogen activator inhibitor-1 in Caucasian patients with non-insulin-dependent diabetes mellitus. Thromb Haemost 74:842-847, 1995
33. TARROW L, CAMBIEN F, ROSSINNG P, NIELSEN FS, HANSEN BV, LECERF L, POIRIER O, DANILOV S, PARVING HH: Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients, Diabetes 44:489-494, 1995
34. SCHMIDT S, SCHÖNE N, RITZ E: Association of ACE gene polymorphism and diabetic nephropathy? The Diabetic Nephropathy Study Group. Kidney Int 47:1176-1181, 1995
35. CHAIT A, BIERMAN E: Pathogenesis of macrovascular disease in diabetes, in Joslin's Diabetes Mellitus (3th ed), edited by KAHN CR, WEIR GC, Philadelphia, Baltimore Lea & Febiger, 1994, pp 648-664
36. PARVING H-H, ØSTERBY R, ANDERSON PW, HSUEH WA: Diabetic nephropathy, in The Kidney (5th ed), edited by BRENXER BM, Philadelphia, WB Saunders, 1996, pp 1864-1892
37. MAUER M, MOGENSEN CE, FRIEDMAN EA: Diabetic nephropathy, in The Disease of the Kidney (6th ed), edited by SCHRIER RW, GOTTSCHALK CW, Boston, New York, Little, Brown and Company, 1997, pp 2019-2061
38. MELTON LJ III, MACKEN KM, PALUMBO PJ, ELVEBACK LR: Incidence and prevalence of clinical peripheral vascular disease in a populationbased cohort of diabetic patients. Diabetes Care 3:650-654, 1980
39. KOGAWA K, NISHZAWA Y, HOSOI M, KAWAGISHI T, MAEKAWA K, SHOJI T, OKUNO Y, MOKII H: Effect of polymorphism of apolipoprotein E and angiotensin-converting enzyme genes on arterial wall thickness. Diabetes 46:682-687, 1997
40. DANSER A, SCHALEKAMP M, BAX W, VAN DEN BRINK A, SAXENA P, RIEGGER G, SHUNKERT H: Angiotensin-converting enzyme in the human heart: Effect of the deletion/insertion polymorphism. Circulation 92:1387-1388, 1995
41. BFCKER NB, HIMMELFARB J, HENRICH WL, HAKIM R: Reassessing the cardiac risk profile in chronic hemodialysis patients: A hypothesis on the role of oxidant stress and other non-traditional cardiac risk factors. J Am Soc Nephrol 8:475-486, 1997
42. MARRE M, JEUNEMAITRE X, GALLOIS Y, RODIER M, CHATELLIER G, SERT C, DUSSELIER L, KAHAL Z, CHALLIOUS L, HALIMI S, MULLER A, SACKMANN H, BAUDUCEAU B, BLED F, PASSA P, ALHENC-GELAS F: Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes. J Clin Invest 99:1585-1595, 1997
43. YOSHIDA H, KON V, ICHIKAWA I: Polymorphism of the renin-angiotensin system genes in progressive renal diseases. Kidney Int 50:732-744, 1996